Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page
- Check7 days agoChange DetectedThe page now includes new metadata fields Last verified and Last known status was:, and adds user help links such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label is reformatted from Interven tion / Treatment, and the footer shows Revision: v3.6.0.SummaryDifference2%

- Check14 days agoChange DetectedThe page’s revision label updated from v3.5.4 to v3.5.5, indicating a small, behind-the-scenes update to the page. No modifications to trial details or visible content are indicated by this change.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision indicator was updated from v3.5.3 to v3.5.4, reflecting a new UI/version update. This change does not affect the trial details or other user-facing information.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page’s revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a site release change rather than any alteration to the underlying study record details.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.